February is upon us and it is a sweetheart of a month. The HCV Advocate newsletter is packed full of interesting news to help in your educational interests. Please share it with your family, friends, and, of course, your sweetheart.
The articles in this month’s newsletter include:
What We Need to Eliminate HCV, by Alan Franciscus. The multimedia review journal Clinical Liver Disease published a series of articles that provided important information about the tools needed to eliminate hepatitis C (HCV). This report is a review of the articles and is specific to the United States. It doesn’t address the political issues that are equally, if not more, important.
I Heart Liver by Lucinda Porter, RN. Sometimes it takes a hepatitis C diagnosis for us to pay attention to the fact that we each have a liver. We learn where the liver is, what it does, and how essential it is. However, the hepatitis C virus (HCV) affects more than just the liver. HCV affects the entire body, particularly the heart and cardiovascular system. Since February is American Heart Month, it is a perfect time to discuss the relationship between the liver and its neighbor, the heart. In particular, we will explore ways to improve cardiovascular health. This information is good for everyone, with or without hepatitis C.
Hepatitis Headlines (1) At Stanford, Term ‘Homosexual’ Will No Longer Be Used When Discussing Spread of Hepatitis, (2) Adherence to ‘Healthy Eating Index’ Diet May Reduce Liver Cancer Risk.
What’s Up! News about the upcoming issue of our last HCV Advocate Newsletter this March, our patient HCV video and Packhealth – a patient resource.
Happy New Year!We hope that 2019 will bring you much joy, happiness and for those with hepatitis C, a cure. I think that 2019 may be the year that we just might turn the corner on screening, access to care and treatment for more people with hepatitis C.
This month’s edition of the HCV Advocate newsletter features the following:
Top News Stories of 2018, by Alan Franciscus. It was an interesting year in HCV that was full of ups and downs but progress is being made in the fight against HCV.
It’s hard to believe that the end of the year is near and the HCV Advocate newsletter is entering its 21st year of publication. This month we have devoted the entire issue to coverage of The Liver Meeting recently held in San Francisco, CA. Lucinda Porter, RN and I are reporting on our favorite posters presented at the meeting. Listed below are the abstracts that we have covered.
#584 Early Treatment with Direct-Acting Antivirals (DAAs) Saves Medical Costs in Non-Cirrhotic Patients with Chronic Hepatitis C (CHC) Virus Infection in the United States (US)- Patrice Cacoub, et. al.
Marijuana is not associated with the progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis
Eight-week hepatitis C treatment with new direct-acting antivirals has a better safety profile while being effective in the treatment-naïve geriatric population without liver cirrhosis and hepatitis C virus-RNA < 6 Million IU/mL
Approaches, progress, and challenges to hepatitis C vaccine development
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: a modeling study
Halloween is almost here and we have some informative but scary articles in this month’s HCV Advocate newsletter:
HealthWise – Jailed for Hepatitis C – by Lucinda Porter, RN is an informative article about making hepatitis C a crime. In fact, in some states, it already is a crime.
“It used to be that having hepatitis C would land you in the doctor’s office. Never in my wildest dreams did I imagine that it could land me in jail. However, theoretically it could.”
Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes—A. Rawshani, et. al.
Incidence of hepatocellular carcinoma after direct antiviral therapy for HCV in patients with cirrhosis included in surveillance programs—P. Nahom, et. al.
Safety and efficacy of ledipasvir‐sofosbuvir with or without ribavirin for chronic hepatitis C in children ages 6‐11—K. F. Murry, et. al
Commentary: A review of the risk of hepatitis B and C transmission through biting or spitting—H. Pintilie, et. al.
Hepatitis C virus infection in children in the era of direct-acting antivirals—M. Pawlowska, et. al
HealthWise – A Buffet of Health Information – as the title of the article implies, Lucinda discusses the various substances that may or may not be good for your health.
Hepatitis Headlines – Three interesting news stories about hepatitis C that our readers will find interesting including heart transplants, eliminating hepatitis in the U.S. and WHO and HCV treatment guidelines.
Hep C 101 – Overview of Hepatitis C by Alan Franciscus – A new series of article for people who are new to hepatitis C or for those people who want basic information.
What’s Up – We’ve updated several of the HCV Advocate Factsheets. Use the links provided in this section to get current information on several subjects that relate to Hep C, including nutrition, alcohol, co-infection, and motherhood.
Watch our patient video about treating and curing HCV.
Pack Health Don’t forget to check out Pack Health: a free resource to help patients navigate their HCV treatment journey from applying for treatment to cure.
Enter your contact info
Use promo code: HCV2017
Get 3 months of membership free! As easy as 1-2-3!
Questions? Call us at 885-255-2362 8am-5pm | Monday-Friday • Get a personal Health Advisor to coach you on your journey • Develop a personalized plan – you set the goals, we’ll help you get there • Find answers and accountability to get the results you want • Use the tools and guides we send you to track your progress. 1. Enter your contact info 2. Use promo code: HCV2017 3. Get 3 months of membership free! As easy as 1-2-3! To Your Health,Alan and the team of the HCV Advocate